Summary
The AI-generated claims substantially misidentify the product/actives relative to the provided FDA label excerpts, which describe SLYND (drospirenone-only) and do not mention Yaz or ethinyl estradiol. As a result, multiple key statements about active ingredients and strengths are unsupported.
Category Scores
Accurate Statements
Unsupported Statements
Yaz is a brand-name oral contraceptive that contains drospirenone and ethinyl estradiol as its active ingredients.
Not supported by the provided label excerpts, which describe SLYND as drospirenone-only and do not mention Yaz or ethinyl estradiol.
Yaz specifically combines drospirenone 3 mg and ethinyl estradiol 0.02 mg in each active pill.
Not supported; provided excerpts state SLYND active white tablets contain 4 mg drospirenone plus inert green tablets that contain no drospirenone, with no ethinyl estradiol strengths or pill regimen described.
Other drospirenone/ethinyl estradiol generics or brands can have different dosing schedules or strengths.
Not addressed in provided excerpts; they only describe SLYND composition.
If a product is labeled as a drospirenone/ethinyl estradiol generic, it uses the same active ingredients as Yaz.
Not supported; Yaz is not mentioned and no drospirenone/ethinyl estradiol generic equivalence statements are present in provided excerpts.
Even if the active ingredients are the same as Yaz, the exact strength (mg) and pill schedule can differ.
Not supported; provided excerpts do not discuss Yaz dosing or comparative strengths/schedules across drospirenone/ethinyl estradiol products.
Different formulations of drospirenone/ethinyl estradiol generics can be close but not exactly the same as Yaz.
Not supported; provided excerpts contain no comparative discussion of Yaz vs other drospirenone/ethinyl estradiol formulations.
A person taking drospirenone and ethinyl estradiol but not Yaz may be using an alternative drospirenone/ethinyl estradiol contraceptive that might differ from Yaz in dosing and/or regimen.
Not supported; provided excerpts describe SLYND as drospirenone-only and do not address Yaz alternatives.
Contradictions
Low
AI Statement
Yaz contains drospirenone and ethinyl estradiol as its active ingredients.
Label Reference
Provided excerpts (11 DESCRIPTION; 2 DOSAGE AND ADMINISTRATION) describe SLYND (drospirenone) only and state the inert green tablets do not contain drospirenone; no ethinyl estradiol is mentioned.
Low
AI Statement
Yaz specifically combines drospirenone 3 mg and ethinyl estradiol 0.02 mg in each active pill.
Label Reference
Provided excerpts specify SLYND white tablets contain 4 mg drospirenone and inert green tablets contain no drospirenone; no ethinyl estradiol strengths are provided.
Important Omissions
No label-supported clarification that the provided label excerpts are for SLYND (drospirenone-only) and do not describe Yaz (drospirenone/ethinyl estradiol).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The claims misidentify active ingredients/strengths relative to the supplied label excerpts, which could mislead about estrogen-containing vs drospirenone-only products. However, specific contraindication/boxed-warning consequences are not assessable from the provided sections.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
AI claims about Yaz (drospirenone/ethinyl estradiol) and its specific strengths are unsupported and conflict with the supplied label excerpts that describe SLYND (drospirenone-only).
Suggested Improvement
Limit claims to the supplied label content (SLYND drospirenone-only; active white tablets contain 4 mg drospirenone with inert green tablets). Do not assert Yaz identity, ethinyl estradiol content, or Yaz dosing/schedule unless the corresponding FDA label sections are provided.